Table of Contents
Table of Contents
1 Industry Overview
1.1 Opioid Induced Constipation Drugs Industry
Figure Opioid Induced Constipation Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Opioid Induced Constipation Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Opioid Induced Constipation Drugs
1.2.2 Downstream
Table Application Segment of Opioid Induced Constipation Drugs
Table Global Opioid Induced Constipation Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Opioid Induced Constipation Drugs Market by Type
3.1 By Type
3.1.1 Lubiprostone 
Table Major Company List of Lubiprostone 
3.1.2 Methyl Naltrexone Bromide 
Table Major Company List of Methyl Naltrexone Bromide 
3.1.3 Naldemedine 
Table Major Company List of Naldemedine 
3.1.4 Alvimopan 
Table Major Company List of Alvimopan 
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Opioid Induced Constipation Drugs Market 2016-2020, by Type, in USD Million
Figure Global Opioid Induced Constipation Drugs Market Growth 2016-2020, by Type, in USD Million
3.3 Market Forecast
Table Global Opioid Induced Constipation Drugs Market Forecast 2021-2026, by Type, in USD Million
4 Major Companies List
4.1 Ironwood Pharmaceuticals Inc  (Company Profile, Sales Data etc.)
4.1.1 Ironwood Pharmaceuticals Inc  Profile
Table Ironwood Pharmaceuticals Inc  Overview List
4.1.2 Ironwood Pharmaceuticals Inc  Products & Services
4.1.3 Ironwood Pharmaceuticals Inc  Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Daiichi Sankyo Co Ltd  (Company Profile, Sales Data etc.)
4.2.1 Daiichi Sankyo Co Ltd  Profile
Table Daiichi Sankyo Co Ltd  Overview List
4.2.2 Daiichi Sankyo Co Ltd  Products & Services
4.2.3 Daiichi Sankyo Co Ltd  Business Operation Conditions
Table Business Operation of Daiichi Sankyo Co Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Pfizer  (Company Profile, Sales Data etc.)
4.3.1 Pfizer  Profile
Table Pfizer  Overview List
4.3.2 Pfizer  Products & Services
4.3.3 Pfizer  Business Operation Conditions
Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Progenics Pharmaceuticals Inc  (Company Profile, Sales Data etc.)
4.4.1 Progenics Pharmaceuticals Inc  Profile
Table Progenics Pharmaceuticals Inc  Overview List
4.4.2 Progenics Pharmaceuticals Inc  Products & Services
4.4.3 Progenics Pharmaceuticals Inc  Business Operation Conditions
Table Business Operation of Progenics Pharmaceuticals Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Shionogi & Co., Ltd  (Company Profile, Sales Data etc.)
4.5.1 Shionogi & Co., Ltd  Profile
Table Shionogi & Co., Ltd  Overview List
4.5.2 Shionogi & Co., Ltd  Products & Services
4.5.3 Shionogi & Co., Ltd  Business Operation Conditions
Table Business Operation of Shionogi & Co., Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Allergan Plc  (Company Profile, Sales Data etc.)
4.6.1 Allergan Plc  Profile
Table Allergan Plc  Overview List
4.6.2 Allergan Plc  Products & Services
4.6.3 Allergan Plc  Business Operation Conditions
Table Business Operation of Allergan Plc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Nektar Therapeutics  (Company Profile, Sales Data etc.)
4.7.1 Nektar Therapeutics  Profile
Table Nektar Therapeutics  Overview List
4.7.2 Nektar Therapeutics  Products & Services
4.7.3 Nektar Therapeutics  Business Operation Conditions
Table Business Operation of Nektar Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Purdue Pharma  (Company Profile, Sales Data etc.)
4.8.1 Purdue Pharma  Profile
Table Purdue Pharma  Overview List
4.8.2 Purdue Pharma  Products & Services
4.8.3 Purdue Pharma  Business Operation Conditions
Table Business Operation of Purdue Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 S.L.A. Pharma AG  (Company Profile, Sales Data etc.)
4.9.1 S.L.A. Pharma AG  Profile
Table S.L.A. Pharma AG  Overview List
4.9.2 S.L.A. Pharma AG  Products & Services
4.9.3 S.L.A. Pharma AG  Business Operation Conditions
Table Business Operation of S.L.A. Pharma AG  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Mundipharma International Limited  (Company Profile, Sales Data etc.)
4.10.1 Mundipharma International Limited  Profile
Table Mundipharma International Limited  Overview List
4.10.2 Mundipharma International Limited  Products & Services
4.10.3 Mundipharma International Limited  Business Operation Conditions
Table Business Operation of Mundipharma International Limited  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Ono Pharmaceutical Co., Ltd  (Company Profile, Sales Data etc.)
4.11.1 Ono Pharmaceutical Co., Ltd  Profile
Table Ono Pharmaceutical Co., Ltd  Overview List
4.11.2 Ono Pharmaceutical Co., Ltd  Products & Services
4.11.3 Ono Pharmaceutical Co., Ltd  Business Operation Conditions
Table Business Operation of Ono Pharmaceutical Co., Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Takeda Pharmaceutical Company Limited  (Company Profile, Sales Data etc.)
4.12.1 Takeda Pharmaceutical Company Limited  Profile
Table Takeda Pharmaceutical Company Limited  Overview List
4.12.2 Takeda Pharmaceutical Company Limited  Products & Services
4.12.3 Takeda Pharmaceutical Company Limited  Business Operation Conditions
Table Business Operation of Takeda Pharmaceutical Company Limited  (Sales Revenue, Cost, Gross Margin)
4.13 Theravance Biopharma Inc  (Company Profile, Sales Data etc.)
4.13.1 Theravance Biopharma Inc  Profile
Table Theravance Biopharma Inc  Overview List
4.13.2 Theravance Biopharma Inc  Products & Services
4.13.3 Theravance Biopharma Inc  Business Operation Conditions
Table Business Operation of Theravance Biopharma Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Valeant Pharmaceuticals International  (Company Profile, Sales Data etc.)
4.14.1 Valeant Pharmaceuticals International  Profile
Table Valeant Pharmaceuticals International  Overview List
4.14.2 Valeant Pharmaceuticals International  Products & Services
4.14.3 Valeant Pharmaceuticals International  Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals International  (Sales Revenue, Cost, Gross Margin)
4.15 Cosmo Pharmaceuticals SA  (Company Profile, Sales Data etc.)
4.15.1 Cosmo Pharmaceuticals SA  Profile
Table Cosmo Pharmaceuticals SA  Overview List
4.15.2 Cosmo Pharmaceuticals SA  Products & Services
4.15.3 Cosmo Pharmaceuticals SA  Business Operation Conditions
Table Business Operation of Cosmo Pharmaceuticals SA  (Sales Revenue, Cost, Gross Margin)
4.16 Daewoong Pharmaceutical  (Company Profile, Sales Data etc.)
4.16.1 Daewoong Pharmaceutical  Profile
Table Daewoong Pharmaceutical  Overview List
4.16.2 Daewoong Pharmaceutical  Products & Services
4.16.3 Daewoong Pharmaceutical  Business Operation Conditions
Table Business Operation of Daewoong Pharmaceutical  (Sales Revenue, Cost, Gross Margin)
4.17 C.B. Fleet Company  (Company Profile, Sales Data etc.)
4.17.1 C.B. Fleet Company  Profile
Table C.B. Fleet Company  Overview List
4.17.2 C.B. Fleet Company  Products & Services
4.17.3 C.B. Fleet Company  Business Operation Conditions
Table Business Operation of C.B. Fleet Company  (Sales Revenue, Cost, Gross Margin)
4.18 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.)
4.18.1 Sucampo Pharmaceuticals Profile
Table Sucampo Pharmaceuticals Overview List
4.18.2 Sucampo Pharmaceuticals Products & Services
4.18.3 Sucampo Pharmaceuticals Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Opioid Induced Constipation Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Opioid Induced Constipation Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Opioid Induced Constipation Drugs Sales Revenue Share in 2020, by Company, in USD Million
5.2 Regional Market by Company
Figure North America Opioid Induced Constipation Drugs Market Concentration, in 2020
Figure Europe Opioid Induced Constipation Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Opioid Induced Constipation Drugs MMarket Concentration, in 2020
Figure South America Opioid Induced Constipation Drugs Market Concentration, in 2020
Figure Middle East & Africa Opioid Induced Constipation Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies 
Figure Opioid Induced Constipation Drugs Demand in Hospital Pharmacies , 2016-2020, in USD Million
6.1.2 Demand in Retail Pharmacies 
Figure Opioid Induced Constipation Drugs Demand in Retail Pharmacies , 2016-2020, in USD Million
6.1.3 Demand in Online Pharmacies
Figure Opioid Induced Constipation Drugs Demand in Online Pharmacies, 2016-2020, in USD Million
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Opioid Induced Constipation Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Opioid Induced Constipation Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Opioid Induced Constipation Drugs Market Share in 2026, by Application, in USD Million
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Opioid Induced Constipation Drugs Production 2016-2020, by Region, in USD Million
7.2 Regional Market
Table Global Opioid Induced Constipation Drugs Market 2016-2020, by Region, in USD Million
Table Global Opioid Induced Constipation Drugs Market Share 2016-2020, by Region, in USD Million
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.3.4 South America
7.3.4.1 Overview
Figure South America Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Opioid Induced Constipation Drugs Market Size and Growth 2016-2020, in USD Million
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Opioid Induced Constipation Drugs Market Size 2016-2020, by Country, in USD Million
7.4 Regional Import & Export
7.5 Regional Forecast
Table Opioid Induced Constipation Drugs Market Forecast 2021-2026, by Region, in USD Million
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion